Published in J Infect Dis on August 01, 1999
Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ (2009) 6.13
Restoring invisible and abandoned trials: a call for people to publish the findings. BMJ (2013) 3.51
The treatment of influenza with antiviral drugs. CMAJ (2003) 1.89
Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities. Antimicrob Agents Chemother (2001) 1.89
Simulation and prediction of the adaptive immune response to influenza A virus infection. J Virol (2009) 1.76
The burden of influenza B: a structured literature review. Am J Public Health (2013) 1.69
Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies. Antimicrob Agents Chemother (2000) 1.66
In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201. Antimicrob Agents Chemother (2001) 1.62
Cost-utility of rapid polymerase chain reaction-based influenza testing for high-risk emergency department patients. Ann Emerg Med (2013) 1.47
Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells. Antimicrob Agents Chemother (2004) 1.41
The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA. J Virol (2000) 1.34
Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: a minireview. Glycoconj J (2006) 1.21
The use of antiviral drugs for influenza: Guidance for practitioners 2012/2013. Can J Infect Dis Med Microbiol (2012) 1.19
Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients. Antimicrob Agents Chemother (2011) 1.16
Management of influenza symptoms in healthy adults. J Gen Intern Med (2003) 1.13
A primer on strategies for prevention and control of seasonal and pandemic influenza. Am J Public Health (2009) 1.13
Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin. J Virol (2014) 1.13
Influenza vaccines: from surveillance through production to protection. Mayo Clin Proc (2010) 1.09
The use of antiviral drugs for influenza: recommended guidelines for practitioners. Can J Infect Dis Med Microbiol (2006) 0.89
Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead. Adv Drug Deliv Rev (2014) 0.87
Antiviral and antibiotic prescribing for influenza in primary care. J Gen Intern Med (2009) 0.87
Zanamivir: from drug design to the clinic. Philos Trans R Soc Lond B Biol Sci (2001) 0.83
Clinical diagnosis of influenza in the ED. Am J Emerg Med (2015) 0.82
Effectiveness of neuraminidase inhibitors in preventing hospitalization during the H1N1 influenza pandemic in British Columbia, Canada. J Antimicrob Chemother (2013) 0.82
Estimating the United States demand for influenza antivirals and the effect on severe influenza disease during a potential pandemic. Clin Infect Dis (2015) 0.81
Statins and influenza: can we move forward? J Infect Dis (2011) 0.81
An overview of the characteristics of the novel avian influenza A H7N9 virus in humans. Front Microbiol (2015) 0.80
The Intranasal Application of Zanamivir and Carrageenan Is Synergistically Active against Influenza A Virus in the Murine Model. PLoS One (2015) 0.79
Influenza testing, diagnosis, and treatment in the emergency department in 2009-2010 and 2010-2011. Acad Emerg Med (2013) 0.78
How to treat influenza and colds. West J Med (2000) 0.77
The battle against influenza: The role of neuraminidase inhibitors in children. Can J Infect Dis (2000) 0.75
Economic evaluations of neuraminidase inhibitors to control influenza. Expert Rev Pharmacoecon Outcomes Res (2003) 0.75
Influenza: New Insights Into an Old Disease. Curr Infect Dis Rep (2000) 0.75
The battle against influenza: The role of neuraminidase inhibitors in children. Paediatr Child Health (2000) 0.75
Efficacy and safety of clearing heat and detoxifying injection in the treatment of influenza: a randomized, double-blinded, placebo-controlled trial. Evid Based Complement Alternat Med (2014) 0.75
Genotyping and detection of common avian and human origin-influenza viruses using a portable chemiluminescence imaging microarray. Springerplus (2016) 0.75
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending-Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza B Monoclonal Antibody, MHAB5553A, in Healthy Volunteers. Antimicrob Agents Chemother (2017) 0.75
Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Challenge Model: A Phase 2 Randomized Trial. Antimicrob Agents Chemother (2017) 0.75
A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med (2001) 16.32
Prevalence of asthma and hay fever in England and Wales. Br Med J (Clin Res Ed) (1987) 12.19
General practitioner referrals to hospital: the financial implications of variability. Health Trends (1988) 8.82
Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science (2004) 8.44
Coverage by the news media of the benefits and risks of medications. N Engl J Med (2000) 7.50
Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med (1997) 6.23
Clinical signs and symptoms predicting influenza infection. Arch Intern Med (2000) 5.83
List size, screening methods, and other characteristics of practices in relation to preventive care. Br Med J (Clin Res Ed) (1985) 5.67
An evaluation of recorded information about preventive measures in 38 practices. J R Coll Gen Pract (1981) 5.00
The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc (2001) 4.99
The incidence of common infectious diseases: the weekly returns service of the Royal College of General Practitioners. Health Trends (1985) 4.90
Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group. Lancet (1998) 4.54
Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet (2004) 4.39
Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet (2001) 4.38
Impact of audit on preventive measures. Br Med J (Clin Res Ed) (1983) 4.19
T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med (1996) 3.88
Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr (1997) 3.80
A simple scoring system for evaluating symptoms, history and urine dipstick testing in the diagnosis of urinary tract infection. J R Coll Gen Pract (1987) 3.61
Promoting cost effective prescribing. BMJ (1995) 3.46
Workload review. Birmingham Research Unit, Royal College of General Practitioners. J R Coll Gen Pract (1982) 3.41
Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations. Intern Med J (2005) 3.08
Suppression of melatonin secretion in some blind patients by exposure to bright light. N Engl J Med (1995) 3.08
Low serum cholesterol and suicide. Br J Psychiatry (1993) 3.04
Comparing treatments. BMJ (1995) 3.02
A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N Engl J Med (1995) 2.88
Cimetidine and tranexamic acid in the treatment of acute upper-gastrointestinal-tract bleeding. N Engl J Med (1983) 2.72
Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med (2000) 2.68
Racial and ethnic differences in parents' assessments of pediatric care in Medicaid managed care. Health Serv Res (2001) 2.68
Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV). J Clin Microbiol (2000) 2.63
[Chickenpox: sufficient reasons for the introduction of vaccination]. Ned Tijdschr Geneeskd (2006) 2.61
Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis. BMJ (1995) 2.61
Comparative study of five different DNA fingerprint techniques for molecular typing of Streptococcus pneumoniae strains. J Clin Microbiol (1995) 2.55
The effects of information framing on the practices of physicians. J Gen Intern Med (1999) 2.52
Structure of the C3HC4 domain by 1H-nuclear magnetic resonance spectroscopy. A new structural class of zinc-finger. J Mol Biol (1994) 2.47
Multiplex reverse transcription-PCR for surveillance of influenza A and B viruses in England and Wales in 1995 and 1996. J Clin Microbiol (1997) 2.45
Comparison between the weekly returns service and the Oxford regional sentinel practice scheme for monitoring communicable diseases. J R Coll Gen Pract (1988) 2.32
Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Int J Syst Evol Microbiol (2001) 2.27
Presentation with influenza-like illness in general practice: implications for use of neuraminidase inhibitors. Commun Dis Public Health (2000) 2.22
Disease mongering: expanding the boundaries of treatable disease. Intern Med J (2008) 2.19
The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther (2007) 2.18
Service profiles of general practitioners in Europe. European GP Task Profile Study. Br J Gen Pract (1997) 2.17
Separation of sequence requirements for HSV-1 Vmw110 multimerisation and interaction with a 135-kDa cellular protein. Virology (1995) 2.14
No epidemiological evidence for infant vaccinations to cause allergic disease. Vaccine (2004) 2.13
Randomised controlled trial of effect of feedback on general practitioners' prescribing in Australia. BMJ (1999) 2.11
CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Leukemia (2013) 2.11
Molecular epidemiology of drug-resistant pneumococci: toward an international approach. Microb Drug Resist (1997) 2.03
Do consumer reports of health plan quality affect health plan selection? Health Serv Res (2000) 2.03
A pilot study of evaluation of cerebral function by S100beta protein and near-infrared spectroscopy during cold and warm cardiopulmonary bypass in infants and children undergoing open-heart surgery. Anaesthesia (2004) 2.01
Novel BOX repeat PCR assay for high-resolution typing of Streptococcus pneumoniae strains. J Clin Microbiol (1996) 2.00
Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors. Diabetes Obes Metab (2011) 1.97
Confirmatory factor analysis of the Consumer Assessment of Health Plans Study (CAHPS) 1.0 Core Survey. Psychol Assess (2001) 1.96
Evaluation of different indirect measures of rate of drug absorption in comparative pharmacokinetic studies. J Pharm Sci (1994) 1.95
Influenza types and patient population. Lancet (1995) 1.94
Understanding ethnic and other socio-demographic differences in patient experience of primary care: evidence from the English General Practice Patient Survey. BMJ Qual Saf (2011) 1.92
Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev (2003) 1.85
Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents. Proc Natl Acad Sci U S A (2006) 1.85
Autologous transfusion techniques: a systematic review of their efficacy. Transfus Med (2004) 1.84
Photoregulation of a phytochrome gene promoter from oat transferred into rice by particle bombardment. Proc Natl Acad Sci U S A (1989) 1.84
Cost comparison between bilateral simultaneous, staged, and unilateral total joint arthroplasty. J Arthroplasty (1998) 1.78
Association between availability of non-prescription beta 2 agonist inhalers and undertreatment of asthma. BMJ (1993) 1.76
Delayed therapy with curative intent in a contemporary prostate cancer watchful-waiting cohort. BJU Int (2004) 1.75
Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology (1997) 1.74
Ethics and evidence based medicine. BMJ (1998) 1.74
A comparison of the practice activities of trainees and principals. J R Coll Gen Pract (1986) 1.71
Pneumococcal vaccines: an update on current strategies. Vaccine (2004) 1.69
Diagnosis and patterns of incidence of influenza, influenza-like illness and the common cold in general practice. J R Coll Gen Pract (1988) 1.66
Synthetic insecticide with a new order of activity. Nature (1974) 1.64
A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med (1996) 1.64
Incidence of episodes of acute asthma and acute bronchitis in general practice 1976-87. Br J Gen Pract (1993) 1.63
Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg (1993) 1.62
Imatinib for systemic mast-cell disease. Lancet (2003) 1.62
Consultation rates in English general practice. J R Coll Gen Pract (1989) 1.61
Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill (2011) 1.61
Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients. Int J Syst Evol Microbiol (2001) 1.61
Host genetic determinants of Neisseria meningitidis infections. Lancet Infect Dis (2003) 1.59
Cranial computed tomography scans in children after minimal head injury with loss of consciousness. Ann Emerg Med (1994) 1.58
Catecholamines in fetal and newborn rat brain. J Neurochem (1973) 1.55
The problem of diagnostic variability in general practice. J Epidemiol Community Health (1992) 1.54
Incidence of allergic rhinitis in general practice, 1981-92. BMJ (1994) 1.53
Early age at repair prevents restrictive right ventricular (RV) physiology after surgery for tetralogy of Fallot (TOF): diastolic RV function after TOF repair in infancy. J Am Coll Cardiol (1998) 1.53
High level expression and purification of herpes simplex virus type 1 immediate early polypeptide Vmw110. Nucleic Acids Res (1991) 1.51
A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppression. Cancer Invest (1998) 1.51
Penicillin-resistant Streptococcus pneumoniae in the Netherlands: results of a 1-year molecular epidemiologic survey. J Infect Dis (1997) 1.51
Clinical comparison of isolator and BACTEC 660 resin media for blood culture. J Clin Microbiol (1990) 1.51
Prognosis in adult asthma: a national study. Br Med J (Clin Res Ed) (1987) 1.49
Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study. J Infect (2000) 1.48
Comparison of Second National Morbidity Study and General Household Survey 1970-71. Health Trends (1986) 1.48
Pathophysiology of meningococcal sepsis in children. Eur J Pediatr (1998) 1.46
Testosterone improves rehabilitation outcomes in ill older men. J Am Geriatr Soc (2000) 1.46
Parental exposure to x-irradiation and Down's syndrome. Ann Hum Genet (1972) 1.46
Conditional stability of the HemA protein (glutamyl-tRNA reductase) regulates heme biosynthesis in Salmonella typhimurium. J Bacteriol (1999) 1.46
Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes. Br J Cancer (2010) 1.46
Validation of 70-gene prognosis signature in node-negative breast cancer. Breast Cancer Res Treat (2008) 1.45
Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol (1997) 1.45
Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc (2000) 1.44
T4 RNA ligase: substrate chain length requirements. FEBS Lett (1974) 1.42
Cloning and characterization of a Na+-driven anion exchanger (NDAE1). A new bicarbonate transporter. J Biol Chem (2000) 1.42
Trial of streptokinase in ischaemic stroke. Lancet (1995) 1.42